Skip to main content
. 2020 Nov 30;11:608248. doi: 10.3389/fendo.2020.608248

Figure 4.

Figure 4

Insulin:glucagon ratio (A) and incretin:glucagon ratio (GLP-1*GIP/Glucagon) (B) combining the two major incretin hormones (GLP-1 and GIP), in post-RYGB patients according to the MMTT response (Hypo and NoHypo). Data is presented as mean ± SEM. Statistically significant differences are marked as **p < 0.01. Abbreviations: GIP, glucose-dependent insulinotropic polypeptide; GLP-1, glucagon-like peptide-1.